Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

36.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Noncanonical Folding of Peptoid Oligomers: Formation of a Closed Conformation in Nonpolar Solvent.

Organic letters·2026
Same author

EtCO2 Instability as an Early Warning During Endoscopic Submucosal Dissection Sedation.

The Korean journal of helicobacter and upper gastrointestinal research·2026
Same author

Integrated analysis of gastric microbiome and clinical features for the diagnosis of gastric neoplasms.

Gut pathogens·2026
Same author

Age-Dependent Effects of Gastric Cancer Screening Endoscopy on Mortality: A Nationwide Cohort Study.

Endoscopy·2026
Same author

One-minute oscillometric vs. continuous arterial pressure monitoring for hypotension during anesthetic induction in low-risk patients: A randomized noninferiority trial.

Journal of clinical anesthesia·2026
Same author

Genomic and Clinical Features Associated with Reduced Susceptibility to Cefiderocol and Cross-resistance to β-lactam/β-lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa.

The Journal of infectious diseases·2026

Related Experiment Video

Updated: Sep 13, 2025

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

8.2K

Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis.

Donghoon Kang1, Yeji Lim1, Dabin Ahn1

  • 1Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.

Journal of Medicinal Chemistry
|July 31, 2025
PubMed
Summary

Researchers developed CPP-CAND, a peptide that targets therapy-induced senescent cancer cells. This peptide disrupts FOXO4-p53 interactions, inducing apoptosis and offering a new strategy against cancer recurrence.

More Related Videos

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

3.1K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

33.8K

Related Experiment Videos

Last Updated: Sep 13, 2025

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

8.2K
Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

3.1K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

33.8K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cellular senescence, characterized by cell cycle arrest and a secretory phenotype, is implicated in aging and cancer recurrence.
  • Chemotherapy-induced senescent cells can evade apoptosis, promoting tumor regrowth.
  • The nuclear interaction between FOXO4 and p53 is critical for senescent cell survival.

Purpose of the Study:

  • To investigate the structural basis of the FOXO4-p53 interaction.
  • To design and evaluate a novel peptide inhibitor targeting this interaction for cancer therapy.

Main Methods:

  • NMR spectroscopy was used to determine the binding interface between FOXO4 and p53.
  • A peptide inhibitor (CPP-CAND) was designed based on structural insights, incorporating a cationic cell-penetrating peptide (CPP) for improved delivery.
  • The efficacy and selectivity of CPP-CAND were assessed in senescent cancer cells.

Main Results:

  • Hydrophobic interactions within the p53 transactivation domain were identified as key for FOXO4 binding.
  • CPP-CAND demonstrated high selectivity for senescent cells, disrupting FOXO4-p53 complexes.
  • CPP-CAND induced caspase-dependent apoptosis in senescent cancer cells, including those treated with doxorubicin and cisplatin.

Conclusions:

  • The structural understanding of FOXO4-p53 interaction enabled the design of an effective peptide inhibitor.
  • CPP-CAND shows promise as a therapeutic agent for selectively eliminating therapy-induced senescent cancer cells.
  • This approach offers a potential strategy to overcome treatment resistance and prevent cancer recurrence.